Photobiomodulation therapy for congenital color vision deficiency: results of a preliminary randomized clinical trial
- PMID: 39748919
- PMCID: PMC11693665
- DOI: 10.3389/fmed.2024.1497501
Photobiomodulation therapy for congenital color vision deficiency: results of a preliminary randomized clinical trial
Abstract
Purpose: This study presents a novel randomized controlled trial investigating photobiomodulation (PBM) therapy as an intervention method for color vision deficiency (CVD).
Methods: A total of 74 participants with CVD were assigned to either the PBM group or the control group. In the PBM group, participants wore virtual reality (VR) goggles twice daily, with a 12-h interval, over a four-week period. The VR video consisted of alternating red and green images, each presented for 5 s, totaling 6 min and 20 s. No treatment was administered to the control group. Color vision improvement was assessed using Yu's, Ishihara's pseudoachromatic plates, Color Blindness Check (CBC), and FM-100 Hue total error score (TES).
Results: After 4 weeks, in terms of Yu's and Ishihara's Plates, the patients in PBM group could identify increasing pieces (before: 1.6 ± 1.6, 2.3 ± 2.2; 4 weeks: 6.5 ± 4.4, 5.4 ± 2.9), while in control group, the number was before: 2.6 ± 3.4, 2.6 ± 2.5; 4 weeks: 3.3 ± 3.6, 2.9 ± 2.2. As for CBC scores, the patients in PBM also showed improved high scores (before: 2353.3 ± 700.0; 4 weeks: 2693.6 ± 642.5). Moreover, PBM treatment resulted in a significant reduction of FM-100 scores (before: 298.0 ± 211.3; 4 weeks: 202.1 ± 114.4).
Conclusion: These findings suggest that PBM therapy holds promise as a potential treatment option for individuals with CVD.
Clinical trial registration: The study received approval from the Ethics Committee of PLA General Hospital, China (KY2021-017). Additionally, it was registered as a Chinese domestic clinical trial (ChiCTR2200056761) at "http://Chictr.org.cn/index.aspx".
Keywords: color vision deficiency; deutan; photobiomodulation; phototherapy; protan.
Copyright © 2024 Liu, Yang, Yu and Jia.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Color vision deficiency among biomedical students: a cross-sectional study.Clin Ophthalmol. 2018 Jun 19;12:1121-1124. doi: 10.2147/OPTH.S160110. eCollection 2018. Clin Ophthalmol. 2018. PMID: 29950807 Free PMC article.
-
Photobiomodulation therapy retarded axial length growth in children with myopia: evidence from a 12-month randomized controlled trial evidence.Sci Rep. 2023 Feb 27;13(1):3321. doi: 10.1038/s41598-023-30500-7. Sci Rep. 2023. PMID: 36849626 Free PMC article. Clinical Trial.
-
Prevalence and gene frequency of color vision impairments among children of six populations from North Indian region.Genes Dis. 2015 Feb 25;2(2):211-218. doi: 10.1016/j.gendis.2015.02.006. eCollection 2015 Jun. Genes Dis. 2015. PMID: 30258865 Free PMC article.
-
Photobiomodulation for non-exudative age-related macular degeneration.Cochrane Database Syst Rev. 2021 May 6;5(5):CD013029. doi: 10.1002/14651858.CD013029.pub2. Cochrane Database Syst Rev. 2021. PMID: 34097768 Free PMC article.
-
[Photobiomodulation in the prevention and the management of side effects of cancer treatments: Bases, results and perspectives].Bull Cancer. 2024 Mar;111(3):314-326. doi: 10.1016/j.bulcan.2023.08.011. Epub 2023 Oct 17. Bull Cancer. 2024. PMID: 37858427 Review. French.
References
-
- Hovis JKJO, Science V. Diagnosis of Defective Colour Vision, vol. 79. 2nd ed. Boston: Butterworth-Heinemann; (2002). 406 p.
-
- Slaby D, Roberts J. Color vision deficiencies in youths 12-17 years of age, United States. Vital and health statistics Series 11, Data from the National Health Survey. (1974) 134:1–41. PMID: - PubMed
LinkOut - more resources
Full Text Sources
Research Materials